Adjuvant Chemotherapy with Nanoparticle Albumin-Bound Paclitaxel and Carboplatin for Stage IB Non-small Cell Lung Cancer

被引：0
|
作者：
Motooka, Y. [1 ]
Matsuishi, K. [2 ]
Maruyama, R. [2 ]
Yoshimoto, K. [3 ]
Sakata, S. [1 ]
Aoki, M. [4 ]
Marutsuka, T. [5 ]
Tanaka, F. [6 ]
Suetsugu, T. [7 ]
Suzuki, M. [1 ]
机构：
[1] Kumamoto Univ Hosp, Kumamoto, Japan
[2] Omuta Tenryo Hosp, Omuta, Japan
[3] Minami Kyushu Hosp, Natl Hosp Org, Aira, Japan
[4] Kagoshima Univ, Sch Med, Kagoshima, Japan
[5] Kumamoto City Hosp, Kumamoto, Japan
[6] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[7] Kagoshima Univ, Kagoshima, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
early stage NSCLC; adjuvant chemotherapy; phase II multicenter clinical trial;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP07.02-10
引用
收藏
页码：S528 / S529
页数：2
相关论文
共 50 条
  • [1] Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer
    Blair, Hannah A.
    Deeks, Emma D.
    DRUGS, 2015, 75 (17) : 2017 - 2024
  • [2] Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer
    Hannah A. Blair
    Emma D. Deeks
    Drugs, 2015, 75 : 2017 - 2024
  • [3] Adjuvant Paclitaxel plus Carboplatin Compared with Observation in Stage IB Non-Small Cell Lung Cancer
    Klautke, Gunther
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (08) : 540 - 541
  • [4] Effectiveness of nanoparticle albumin-bound paclitaxel plus carboplatin in non-small lung cancer patients with malignant pleural effusion
    Koyama, N.
    Watanabe, Y.
    Iwai, Y.
    Miwa, C.
    Nagai, Y.
    Aoshiba, K.
    Nakamura, H.
    NEOPLASMA, 2018, 65 (01) : 132 - +
  • [5] The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease
    Yasuda, Yuichiro
    Hattori, Yoshihiro
    Tohnai, Rie
    Ito, Shoichi
    Kawa, Yoshitaka
    Kono, Yuko
    Urata, Yoshiko
    Nogami, Munenobu
    Takenaka, Daisuke
    Negoro, Shunichi
    Satouchi, Miyako
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (01) : 89 - 93
  • [6] Concurrent Albumin-Bound Paclitaxel and/or Carboplatin With Radiation Therapy for the Treatment of Locally Advanced Non-Small Cell Lung Cancer
    Wang, S.
    Sun, X.
    Zhang, H.
    Yu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E439 - E439
  • [7] Nanoparticle Albumin-bound Paclitaxel (NabP) As A Single Agent For The Treatment Of Recurrent Stage 4 Non-small Cell Lung Cancer (NSCLC).
    Saxena, A.
    Christos, P. J.
    Cagney, J. M.
    Scheff, R. J.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S310 - S311
  • [8] Adjuvant Chemotherapy for Patients with Stage IB Non-Small Cell Lung Cancer
    Wang, Jia
    Yue, Yang
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S641 - S642
  • [9] Neoadjuvant or adjuvant paclitaxel and carboplatin for stages IB and II non-small cell lung cancer (NSCLC)
    Hainsworth, JD
    Burris, HA
    Greco, FA
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 27 - 27
  • [10] Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell Lung Cancer
    Reynolds, Craig
    Barrera, David
    Jotte, Robert
    Spira, Alexander I.
    Weissman, Charles
    Boehm, Kristi A.
    Pritchard, Sharon
    Asmar, Lina
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (12) : 1537 - 1543
12345